Production (Stage)
CRISPR Therapeutics AG
CRSP
$42.09
$0.7251.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.99% | 12.41% | 11.26% | 13.21% | 11.95% |
| Total Receivables | -- | -86.88% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -23.25% | -21.30% | -60.28% | -59.07% | -53.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -11.89% | 1.52% | 10.41% | 8.11% | 11.09% |
|
|
|||||
| Total Current Assets | -11.89% | 1.52% | 10.41% | 8.11% | 11.09% |
| Net Property, Plant & Equipment | -9.65% | -9.28% | -8.81% | -8.46% | -5.40% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -96.49% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 37.85% | 101.59% | 97.53% | 90.79% | 44.26% |
| Total Assets | -11.19% | 0.56% | 8.11% | 6.50% | 8.67% |
|
|
|||||
| Total Accounts Payable | -20.65% | -61.44% | -40.43% | -65.74% | -63.54% |
| Total Accrued Expenses | -72.72% | -3.10% | -7.88% | -3.31% | 181.24% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.47% | 10.64% | 12.55% | 10.91% | 1.75% |
| Total Finance Division Other Current Liabilities | -12.66% | 14.12% | -30.78% | 25.67% | 41.42% |
| Total Other Current Liabilities | -12.66% | 14.12% | -30.78% | 25.67% | 41.42% |
| Total Current Liabilities | 0.38% | -19.31% | -19.26% | -3.77% | -18.94% |
|
|
|||||
| Total Current Liabilities | 0.38% | -19.31% | -19.26% | -3.77% | -18.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.80% | -7.44% | -7.03% | -6.72% | -2.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.82% | 5.32% | -24.59% | -8.86% | -5.33% |
| Total Liabilities | -5.11% | -10.62% | -11.86% | -5.80% | -8.83% |
|
|
|||||
| Common Stock & APIC | 3.91% | 14.43% | 15.37% | 15.16% | 15.86% |
| Retained Earnings | -34.55% | -36.64% | -22.00% | -27.21% | -24.15% |
| Treasury Stock & Other | 352.35% | -3.94% | 253.10% | 67.22% | 82.92% |
| Total Common Equity | -12.23% | 2.62% | 12.26% | 9.08% | 12.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.23% | 2.62% | 12.26% | 9.08% | 12.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.23% | 2.62% | 12.26% | 9.08% | 12.35% |
|
|
|||||